In fact, the analysis of CD44 transcript levels in these two liver cancer cell lines showed an aberrant expression of CD44 in Huh7, in comparison with HepG2 cells in which the CD44 receptor was almost absent, suggesting that CD44 expression progressively increases during the acquisition of a more aggressive phenotype. This evidence concerns the gene CD44 and liver cancer.